• Facebook
  • Twitter
Phone: (843) 449-1010 | 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572
Carolina Urologic Research Center - Myrtle Beach, SC
  • Home
  • About Us
  • Staff
    • Clinical Investigators
    • Clinical Staff
    • Associated Providers
  • Current Trials
    • Bladder Cancer
    • Prostate Cancer
    • Other
    • Patient Trials Form
  • Patient Info
    • Patient Info
    • Helpful Links
    • Q&A About Clinical Trials
  • Testimonials
  • In The News
    • In The News
  • Contact
  • Search
  • Menu Menu
Blog - Latest News
You are here: Home1 / Dr. Shore Conducts the Poster Presentation at the SUO 2015 Conference in Washington, DC “Significant Reduction in Therapeutic Burden from Use of CCP Test in Treatment Decisions among Newly Diagnosed Prostate Cancer Patients in a Large Prospective Registry” Please join us Wednesday, 12/2 • 4:30pm2 / 12.1-Prolaris

12.1-Prolaris

December 1, 2015/by CURC

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
/wp-content/uploads/logo-1.png 0 0 CURC /wp-content/uploads/logo-1.png CURC2015-12-01 09:08:342015-12-01 09:08:3412.1-Prolaris

Current Happenings

  • Dr. Shore Presents Practice-Changing Data In Prostate Cancer / EMBARK points to potential new standard of care for high-risk BCR.
  • AUA Chicago April 28 – May 1, 2023- Here We Come
  • Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
  • Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
  • Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
  • Comparison of Germline Mutations In African American And Caucasian Men With Metastatic Prostate Cancer
  • Niraparib With Androgen Receptor-Axis-Targeted Therapy In Patients With Metastatic Castration-Resistant Prostate Cancer: Safety And Pharmacokinetic Results From A Phase 1b Study (BEDIVERE)
  • Combined Advanced Prostate Cancer Treatments- Are They Additive?

Archives

Contact

Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572

Phone: (843) 839-1679
Fax: (843) 286-0119

Email:
info@curcmb.com

Directions

Recent Happenings

  • Dr. Shore Presents Practice-Changing Data In Prostate Cancer / EMBARK points to potential new standard of care for high-risk BCR.
  • AUA Chicago April 28 – May 1, 2023- Here We Come
  • Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
  • Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia

Our Affiliates

©2023 Carolina Urologic Research Center, LLC | All Rights Reserved | Site Design by Studio303, Inc.
  • Facebook
  • Twitter
Scroll to top